Co-Delivery of Autoantigen and Dexamethasone in Incomplete Freund’s Adjuvant Ameliorates Experimental Autoimmune Encephalomyelitis

Current therapies for autoimmune diseases focus on treating the symptoms rather than the underlying disease cause. A major setback in improving current therapeutics for autoimmunity is the lack of antigen specificity. Successful antigen-specific immunotherapy (ASIT) would allow for improved treatmen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Control Release
Päätekijät: Northrup, Laura, Daniel Griffin, J., Christopher, Matthew A., Antunez, Lorena R., Hartwell, Brittany L., Pickens, Chad J., Berkland, Cory
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5723532/
https://ncbi.nlm.nih.gov/pubmed/28963036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.09.034
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia